首页 > 最新文献

Tanaffos最新文献

英文 中文
A Comprehensive Study on the Correlation of Treatment, Diagnosis and Epidemiology of Tuberculosis and Lung Cancer. 肺结核与癌症治疗、诊断及流行病学相关性的综合研究。
Q3 Medicine Pub Date : 2023-01-01
Mojgan Sheikhpour, Seyedeh Nasim Mirbahari, Makan Sadr, Mobina Maleki, Mohadeseh Arabi, Hanie Abolfathi

The correlation between tuberculosis (TB) and lung cancer (LC) in diagnosis, epidemiology, and treatment is still unclear. Based on different cohort and retrospective studies, this correlation could be justified by immune weakness because of exposure to TB which may increase the risk of LC. In this study, we tried to exhibit a prominent connection between TB and LC. The diagnosis and treatment of patients with concomitant TB and LC differ from patients with only one of the diseases. In this review, it was well clarified that the most practical diagnostic method for LC is chest tomography, biopsy, and histopathology, and for pulmonary TB sputum microscopic examination, Autofluorescence bronchoscopy (AFB), culture, and PCR. Also, immunological methods can be a good alternative for differential diagnosis. Most epidemiological studies were about concomitant TB and LC in TB-endemic areas, especially in the Middle East. The most suggested methods for definite treatment of LC are chemotherapy, radiotherapy, and surgery while for TB, a long course of anti-TB therapy can be used. Moreover, immunotherapy is considered a good treatment for lung cancer if the interferon-gamma release assay (IGRA) is negative.

肺结核(TB)和癌症(LC)在诊断、流行病学和治疗方面的相关性尚不清楚。基于不同的队列和回顾性研究,这种相关性可以通过暴露于结核病而导致的免疫无力来证明,这可能会增加LC的风险。在这项研究中,我们试图展示结核病和LC之间的显著联系。合并结核病和LC的患者的诊断和治疗与仅患有其中一种疾病的患者不同。在这篇综述中,明确了LC最实用的诊断方法是胸部断层扫描、活检和组织病理学,以及肺结核痰镜检查、自体荧光支气管镜(AFB)、培养和PCR。此外,免疫学方法可能是鉴别诊断的一个很好的替代方法。大多数流行病学研究都是关于结核病流行地区,特别是中东地区同时发生的结核病和LC。最推荐的明确治疗LC的方法是化疗、放疗和手术,而对于TB,可以使用长疗程的抗TB治疗。此外,如果干扰素-γ释放测定(IGRA)为阴性,免疫疗法被认为是治疗癌症的好方法。
{"title":"A Comprehensive Study on the Correlation of Treatment, Diagnosis and Epidemiology of Tuberculosis and Lung Cancer.","authors":"Mojgan Sheikhpour,&nbsp;Seyedeh Nasim Mirbahari,&nbsp;Makan Sadr,&nbsp;Mobina Maleki,&nbsp;Mohadeseh Arabi,&nbsp;Hanie Abolfathi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The correlation between tuberculosis (TB) and lung cancer (LC) in diagnosis, epidemiology, and treatment is still unclear. Based on different cohort and retrospective studies, this correlation could be justified by immune weakness because of exposure to TB which may increase the risk of LC. In this study, we tried to exhibit a prominent connection between TB and LC. The diagnosis and treatment of patients with concomitant TB and LC differ from patients with only one of the diseases. In this review, it was well clarified that the most practical diagnostic method for LC is chest tomography, biopsy, and histopathology, and for pulmonary TB sputum microscopic examination, Autofluorescence bronchoscopy (AFB), culture, and PCR. Also, immunological methods can be a good alternative for differential diagnosis. Most epidemiological studies were about concomitant TB and LC in TB-endemic areas, especially in the Middle East. The most suggested methods for definite treatment of LC are chemotherapy, radiotherapy, and surgery while for TB, a long course of anti-TB therapy can be used. Moreover, immunotherapy is considered a good treatment for lung cancer if the interferon-gamma release assay (IGRA) is negative.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618578/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges in Providing Care for Patients with Chronic Diseases during Disasters: A Qualitative Study with Focus on Diabetes and Chronic Respiratory Diseases in Iran. 灾难期间为慢性病患者提供护理的挑战:一项针对伊朗糖尿病和慢性呼吸系统疾病的定性研究。
Q3 Medicine Pub Date : 2023-01-01
Elham Ghazanchaei, Kiyoumars Allahbakhshi, Davoud Khorasani-Zavareh, Javad Aghazadeh-Attari, Iraj Mohebbi

Background: Non-communicable diseases are of the major health challenges and the leading cause of death in Iran and at the global level. Moreover, Iran is a disaster-prone country and considering the exacerbation of diabetes and chronic respiratory diseases in natural disasters, its healthcare system is facing challenges. This study was designed to explore challenges in providing healthcare services to patients with diabetes and chronic respiratory diseases during disasters in Iran.

Materials and methods: The conventional content analysis is used in this qualitative study. Participants included 46 patients with diabetes and chronic respiratory diseases, and 36 of stakeholders were experienced and had theoretical knowledge. Participants' selection started by means of purposive sampling and continued to the point of data saturation. Data collection was carried out employing semi-structured interviews. Data analysis was performed using Graneheim and Lundman method.

Results: Based on participants' experiences, four major challenges in providing care to patients with diabetes and chronic respiratory diseases during natural disasters include integrated management (with three subcategories: control and supervision, patient data management, volunteer management), physical, psychosocial health (with three subcategories: psychological impacts, exacerbation of signs and symptoms, special patient characteristics), health literacy and the behavior (with three subcategories: risk perception, values and beliefs, education and awareness) and barriers to healthcare delivery (with three subcategories: facilities and human resources, financial and living problems and insurances, accessibilities and geographic access).

Conclusion: Developing countermeasures against medical monitoring system shutdown in order to detect medical needs and problems faced by chronic disease patients including those with diabetes and chronic obstructive pulmonary disease (COPD), is essential in preparedness for future disasters. Developing effective solutions may result in improved preparedness and better planning of diabetic and COPD patients for disasters, and potentially promote health outcomes during and after disasters.

背景:非传染性疾病是伊朗和全球范围内的主要健康挑战和主要死亡原因。此外,伊朗是一个易受灾国家,考虑到糖尿病和慢性呼吸道疾病在自然灾害中的恶化,其医疗系统面临挑战。这项研究旨在探讨在伊朗灾难期间为糖尿病和慢性呼吸道疾病患者提供医疗服务的挑战。材料与方法:本研究采用常规的内容分析法。参与者包括46名糖尿病和慢性呼吸系统疾病患者,其中36名利益相关者具有丰富的经验和理论知识。参与者的选择从有目的的抽样开始,一直持续到数据饱和。数据收集采用半结构化访谈。数据分析采用Graneheim和Lundman方法。结果:根据参与者的经验,在自然灾害期间为糖尿病和慢性呼吸系统疾病患者提供护理的四大挑战包括综合管理(分为三个子类别:控制和监督、患者数据管理、志愿者管理)、物理、,心理社会健康(分为三个子类:心理影响、体征和症状恶化、特殊患者特征),健康素养和行为(有三个子类别:风险感知、价值观和信念、教育和意识)以及医疗保健提供的障碍(有三子类别:设施和人力资源、财务和生活问题以及保险、可及性和地理可及性)。结论:制定医疗监测系统关闭的对策,以检测包括糖尿病和慢性阻塞性肺病(COPD)患者在内的慢性病患者的医疗需求和面临的问题,对于应对未来的灾难至关重要。开发有效的解决方案可能会提高糖尿病和慢性阻塞性肺病患者对灾难的准备和更好的规划,并有可能促进灾难期间和之后的健康结果。
{"title":"Challenges in Providing Care for Patients with Chronic Diseases during Disasters: A Qualitative Study with Focus on Diabetes and Chronic Respiratory Diseases in Iran.","authors":"Elham Ghazanchaei,&nbsp;Kiyoumars Allahbakhshi,&nbsp;Davoud Khorasani-Zavareh,&nbsp;Javad Aghazadeh-Attari,&nbsp;Iraj Mohebbi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Non-communicable diseases are of the major health challenges and the leading cause of death in Iran and at the global level. Moreover, Iran is a disaster-prone country and considering the exacerbation of diabetes and chronic respiratory diseases in natural disasters, its healthcare system is facing challenges. This study was designed to explore challenges in providing healthcare services to patients with diabetes and chronic respiratory diseases during disasters in Iran.</p><p><strong>Materials and methods: </strong>The conventional content analysis is used in this qualitative study. Participants included 46 patients with diabetes and chronic respiratory diseases, and 36 of stakeholders were experienced and had theoretical knowledge. Participants' selection started by means of purposive sampling and continued to the point of data saturation. Data collection was carried out employing semi-structured interviews. Data analysis was performed using Graneheim and Lundman method.</p><p><strong>Results: </strong>Based on participants' experiences, four major challenges in providing care to patients with diabetes and chronic respiratory diseases during natural disasters include integrated management (with three subcategories: control and supervision, patient data management, volunteer management), physical, psychosocial health (with three subcategories: psychological impacts, exacerbation of signs and symptoms, special patient characteristics), health literacy and the behavior (with three subcategories: risk perception, values and beliefs, education and awareness) and barriers to healthcare delivery (with three subcategories: facilities and human resources, financial and living problems and insurances, accessibilities and geographic access).</p><p><strong>Conclusion: </strong>Developing countermeasures against medical monitoring system shutdown in order to detect medical needs and problems faced by chronic disease patients including those with diabetes and chronic obstructive pulmonary disease (COPD), is essential in preparedness for future disasters. Developing effective solutions may result in improved preparedness and better planning of diabetic and COPD patients for disasters, and potentially promote health outcomes during and after disasters.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618573/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics and Outcomes of COVID-19 Patients in Mazandaran Province, Iran. 伊朗马赞德兰省新冠肺炎患者的临床特征和结果。
Q3 Medicine Pub Date : 2023-01-01
Faezeh Sadat Movahedi, Jamshid Yazdani Charati, Farhang Baba Mahmoudi, Fatemeh Abdollahi, Fatemeh Safari Hajikalai

Background: The problem issue of coronaviruses is one of the most serious problems in the world. The present study aimed to investigate and describe the clinical characteristics, risk factors of fatality rate, and length of hospital stay in patients with COVID-19 in Mazandaran province.

Materials and methods: In this epidemiological study, data from COVID-19 patients admitted to hospitals in Mazandaran province from July 22 to August 21, 2020, were reported. Multivariate logistic regression methods and the Cox proportional hazards model were used to determine the risk factors of fatality.

Results: Out of the 6759 hospitalized patients, 3111(46.03%) patients had comorbidity; 19.77% of them had diabetes, 19.97% had hypertension, and 15.28% had heart failure. Cox regression model on COVID-19 patient data showed that risk factors for fatality including having age over 60 years (HR: 1.93; P< 0.001), intubation (HR: 4.22; P<0.001), SpO2≤ 93% (HR: 2.57; P=0.006), comorbidities of cancer (HR: 1.87; P=0.006), chronic blood diseases (HR: 1.83; P=0.049), heart failure (HR: 1.63; P<0.001), and chronic kidney disease (HR: 1.98; P<0.001).

Conclusion: Paying much attention to risk factors for fatality can help identify patients with a poor prognosis in the early stages. More assessments should also be performed to examine the underlying mechanisms of these risk factors. Highlighting death-relate d risk factors is crucial to increase preparedness through appropriate medical care and prevention regulations.

背景:冠状病毒问题是世界上最严重的问题之一。本研究旨在调查和描述马赞德兰省新冠肺炎患者的临床特征、病死率危险因素和住院时间。材料和方法:在本流行病学研究中,报告了2020年7月22日至8月21日马赞德兰省医院收治的新冠肺炎患者的数据。采用多变量逻辑回归方法和Cox比例危险模型来确定死亡的危险因素。结果:6759例住院患者中,3111例(46.03%)有合并症;其中19.77%患有糖尿病,19.97%患有高血压,15.28%患有心力衰竭。新冠肺炎患者数据的Cox回归模型显示,死亡风险因素包括年龄超过60岁(HR:1.93;P<0.001)、插管(HR:4.22;P2≤93%(HR:2.57;P=0.006)、癌症合并症(HR:1.87;P=0.006),心力衰竭(HR:1.63;P结论:高度关注死亡的风险因素有助于在早期识别预后不良的患者。还应进行更多的评估,以检查这些风险因素的潜在机制。强调与死亡相关的风险因素对于通过适当的医疗护理和预防法规提高准备至关重要。
{"title":"Clinical Characteristics and Outcomes of COVID-19 Patients in Mazandaran Province, Iran.","authors":"Faezeh Sadat Movahedi,&nbsp;Jamshid Yazdani Charati,&nbsp;Farhang Baba Mahmoudi,&nbsp;Fatemeh Abdollahi,&nbsp;Fatemeh Safari Hajikalai","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The problem issue of coronaviruses is one of the most serious problems in the world. The present study aimed to investigate and describe the clinical characteristics, risk factors of fatality rate, and length of hospital stay in patients with COVID-19 in Mazandaran province.</p><p><strong>Materials and methods: </strong>In this epidemiological study, data from COVID-19 patients admitted to hospitals in Mazandaran province from July 22 to August 21, 2020, were reported. Multivariate logistic regression methods and the Cox proportional hazards model were used to determine the risk factors of fatality.</p><p><strong>Results: </strong>Out of the 6759 hospitalized patients, 3111(46.03%) patients had comorbidity; 19.77% of them had diabetes, 19.97% had hypertension, and 15.28% had heart failure. Cox regression model on COVID-19 patient data showed that risk factors for fatality including having age over 60 years (HR: 1.93; P< 0.001), intubation (HR: 4.22; P<0.001), SpO<sub>2</sub>≤ 93% (HR: 2.57; P=0.006), comorbidities of cancer (HR: 1.87; P=0.006), chronic blood diseases (HR: 1.83; P=0.049), heart failure (HR: 1.63; P<0.001), and chronic kidney disease (HR: 1.98; P<0.001).</p><p><strong>Conclusion: </strong>Paying much attention to risk factors for fatality can help identify patients with a poor prognosis in the early stages. More assessments should also be performed to examine the underlying mechanisms of these risk factors. Highlighting death-relate d risk factors is crucial to increase preparedness through appropriate medical care and prevention regulations.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618590/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Rose Water Mouthwash on Prevention of Ventilator-Associated Pneumonia in Intensive Care Unit: A Randomized Controlled Trial. 玫瑰水漱口液对重症监护室预防呼吸机相关性肺炎的影响:一项随机对照试验。
Q3 Medicine Pub Date : 2023-01-01
Faramarz Dobakhti, Mahsa Eskandari, Mahdi Tavakolizadeh, Narges Forouzideh, Parmida Dobakhti, Mohammadreza Jamshidi, Taraneh Naghibi

Background: Preventing Ventilator- Associated Pneumonia (VAP) is an important strategy to increase the quality of provided care for patients under mechanical ventilation. Rose water is the main product of Rosa damascena which is a popular medicinal plant and has been widely used in alternative medicine. It has antibacterial activity against gram-negative and gram-positive bacteria which can potentially cause VAP.

Materials and methods: This study was a randomized, controlled, single-center trial. 88 patients in a 21-bed surgical Intensive Care Unit (ICU) who were under mechanical ventilation met the inclusion criteria, and 80 patients fulfilled the study. Based on receiving either rose water and chlorhexidine solution or chlorhexidine solution alone, the patients were divided into two groups of control and intervention. The incidence of VAP up to 14 days was the primary outcome. Duration of mechanical ventilation, the ICU length of stay, and mortality in ICU were the secondary outcomes.

Results: There was no significant difference in demographic data, the incidence of VAP, the incidence of late-onset VAP, mechanical ventilation days, length of the ICU stay, and mortality between the two groups. However, the incidence of early-onset VAP in the intervention group was significantly lower than in the control group (p= 0.021).

Conclusion: Rose water mouthwash significantly reduced the risk of early-onset VAP without any effect on late-onset VAP.

背景:预防呼吸机相关性肺炎(VAP)是提高机械通气患者护理质量的重要策略。玫瑰水是大马士革罗莎的主要产品,大马士革罗莎是一种受欢迎的药用植物,在替代医学中有着广泛的应用。它对可能导致VAP的革兰氏阴性菌和革兰氏阳性菌具有抗菌活性。材料和方法:本研究为随机、对照、单中心试验。在一个拥有21张床位的外科重症监护室(ICU)中,88名接受机械通气的患者符合纳入标准,80名患者符合研究要求。根据接受玫瑰水和氯己定溶液或单独使用氯己定,将患者分为对照组和干预组。VAP发生率达14天是主要结果。机械通气持续时间、ICU住院时间和ICU死亡率是次要结果。结果:两组在人口统计学数据、VAP发病率、晚发性VAP发生率、机械通气天数、ICU住院时间和死亡率方面没有显著差异。然而,干预组早发性VAP的发生率显著低于对照组(p=0.021)。
{"title":"Impact of Rose Water Mouthwash on Prevention of Ventilator-Associated Pneumonia in Intensive Care Unit: A Randomized Controlled Trial.","authors":"Faramarz Dobakhti,&nbsp;Mahsa Eskandari,&nbsp;Mahdi Tavakolizadeh,&nbsp;Narges Forouzideh,&nbsp;Parmida Dobakhti,&nbsp;Mohammadreza Jamshidi,&nbsp;Taraneh Naghibi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Preventing Ventilator- Associated Pneumonia (VAP) is an important strategy to increase the quality of provided care for patients under mechanical ventilation. Rose water is the main product of <i>Rosa damascena</i> which is a popular medicinal plant and has been widely used in alternative medicine. It has antibacterial activity against gram-negative and gram-positive bacteria which can potentially cause VAP.</p><p><strong>Materials and methods: </strong>This study was a randomized, controlled, single-center trial. 88 patients in a 21-bed surgical Intensive Care Unit (ICU) who were under mechanical ventilation met the inclusion criteria, and 80 patients fulfilled the study. Based on receiving either rose water and chlorhexidine solution or chlorhexidine solution alone, the patients were divided into two groups of control and intervention. The incidence of VAP up to 14 days was the primary outcome. Duration of mechanical ventilation, the ICU length of stay, and mortality in ICU were the secondary outcomes.</p><p><strong>Results: </strong>There was no significant difference in demographic data, the incidence of VAP, the incidence of late-onset VAP, mechanical ventilation days, length of the ICU stay, and mortality between the two groups. However, the incidence of early-onset VAP in the intervention group was significantly lower than in the control group (p= 0.021).</p><p><strong>Conclusion: </strong>Rose water mouthwash significantly reduced the risk of early-onset VAP without any effect on late-onset VAP.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618586/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Involvement of NLRP3 Inflammasome in SARS-Cov-2-Induced Multiorgan Dysfunction in Patients with COVID-19: A Review of Molecular Mechanisms. NLRP3炎症小体参与新冠肺炎患者SARS-Cov-2诱导的多器官功能障碍:分子机制综述。
Q3 Medicine Pub Date : 2023-01-01
Zahra Babazadeh

Nucleotide-binding domain and leucine-rich repeat protein- 3 (NLRP3) inflammasome is a critical component of the innate immune system. The inflammasome activation is correlated with the COVID- 19 severity. Furthermore, the underlying conditions are accompanied by hyperactivation of NLRP3 inflammasome and poor outcomes. Herein, we presented the involvement of NLRP3 inflammasome in the pathogenies of SARS-CoV-2-induced multiorgan dysfunction and potential therapeutics. Overexpression of NLRP3 inflammasome components and subsequently increased levels of cytokines following viral infection leads to the cytokine storm and indirectly affects the organ functions. Besides, invading host cells via SARS-CoV-2 further activates the NLRP3 inflammasome and induces pyroptosis in immune cells, resulting in the secretion of higher levels of proinflammatory cytokines into the extracellular matrix. These events continued by induction of fibrosis and organ dysfunction following infection with SARS-CoV-2 in critically ill patients. This condition can be observed in individuals with comorbidities (e.g., diabetes, obesity, etc.) due to a primed state of immunity, which can cause severe disease or death in this population. Therefore, understanding the mechanisms underlying host-SARS-CoV-2 interaction may help to clarify the pathophysiology of SARS-CoV-2- induced multiorgan dysfunction and introduce potential therapeutic strategies.

核苷酸结合结构域和富含亮氨酸重复蛋白-3(NLRP3)炎症小体是先天免疫系统的关键组成部分。炎症小体的激活与COVID-19的严重程度相关。此外,潜在的疾病伴有NLRP3炎症小体的过度激活和不良结果。在此,我们介绍了NLRP3炎症小体在严重急性呼吸系统综合征冠状病毒2型引起的多器官功能障碍的病因中的作用以及潜在的治疗方法。病毒感染后NLRP3炎症小体成分的过度表达以及随后细胞因子水平的升高导致细胞因子风暴,并间接影响器官功能。此外,通过严重急性呼吸系统综合征冠状病毒2型入侵宿主细胞进一步激活NLRP3炎症小体,并诱导免疫细胞中的焦下垂,导致更高水平的促炎细胞因子分泌到细胞外基质中。危重患者感染严重急性呼吸系统综合征冠状病毒2型后,这些事件通过诱导纤维化和器官功能障碍而持续。这种情况可以在患有合并症(如糖尿病、肥胖等)的个体中观察到,这些合并症是由于免疫启动状态所致,这可能会导致该人群中的严重疾病或死亡。因此,了解宿主-SARS-CoV-2相互作用的机制可能有助于阐明严重急性呼吸系统综合征冠状病毒2诱导的多器官功能障碍的病理生理学,并引入潜在的治疗策略。
{"title":"Involvement of NLRP3 Inflammasome in SARS-Cov-2-Induced Multiorgan Dysfunction in Patients with COVID-19: A Review of Molecular Mechanisms.","authors":"Zahra Babazadeh","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Nucleotide-binding domain and leucine-rich repeat protein- 3 (NLRP3) inflammasome is a critical component of the innate immune system. The inflammasome activation is correlated with the COVID- 19 severity. Furthermore, the underlying conditions are accompanied by hyperactivation of NLRP3 inflammasome and poor outcomes. Herein, we presented the involvement of NLRP3 inflammasome in the pathogenies of SARS-CoV-2-induced multiorgan dysfunction and potential therapeutics. Overexpression of NLRP3 inflammasome components and subsequently increased levels of cytokines following viral infection leads to the cytokine storm and indirectly affects the organ functions. Besides, invading host cells via SARS-CoV-2 further activates the NLRP3 inflammasome and induces pyroptosis in immune cells, resulting in the secretion of higher levels of proinflammatory cytokines into the extracellular matrix. These events continued by induction of fibrosis and organ dysfunction following infection with SARS-CoV-2 in critically ill patients. This condition can be observed in individuals with comorbidities (e.g., diabetes, obesity, etc.) due to a primed state of immunity, which can cause severe disease or death in this population. Therefore, understanding the mechanisms underlying host-SARS-CoV-2 interaction may help to clarify the pathophysiology of SARS-CoV-2- induced multiorgan dysfunction and introduce potential therapeutic strategies.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618576/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Anemia and its Relation with Shwachman Score in Children with Cystic Fibrosis. 囊性纤维化儿童贫血患病率及其与Shwachman评分的关系。
Q3 Medicine Pub Date : 2023-01-01
Mona Afifi, Maryam Hassanzad, Fatemeh Malek, Sharareh Kamfar, Mihan Pourabdollah, Poopak Farnia, Nooshin Baghaei, Ali Valinejadi, Ali Akbar Velayati

Background: Cystic fibrosis is a chronic and progressive genetic disease with a worldwide prevalence. As the disease progresses, symptoms develop, and make its management more challenging. Accumulating evidence suggests that early diagnosis of CF can significantly contribute to preventing reported nutritional problems including anemia, vitamin deficiencies, and hypoalbuminemia. This cross-sectional study was conducted to assess disease severity in cystic fibrosis patients using the Shwachman-Kulczycki score, as well as to determine its relation with anemia and vitamin D deficiency.

Materials and methods: Clinical and CF-related laboratory data were collected from the medical records of 57 CF patients with a definitive diagnosis. At the time of diagnosis, physicians performed simultaneous, blood sampling and scoring of patients using the Shwachman scoring system.

Results: The mean age of patients was 16.12±6.48 years. Total scores of 86-100, 71-85, 56-70, 41-55, and <40, were reported in 5.4%, 7.1%, 14.3%, 14.3%, and 58.9% of CF patients, respectively. A significant correlation was found between disease severity and patients' age (P=0.02). The analysis also showed that the disease severity was significantly higher in anemic patients when compared to non-anemics (p =0.006). Based on the results, 33 patients with normochromic, 11 patients with microcytic, and 6 patients with macrocytic anemia were diagnosed in this study. We did not find a significant difference between disease severity and vitamin D levels (P=0.150).

Conclusion: The scoring system used in the current study could reflect properly the clinical status of CF patients. However, simultaneous use of various methods using a larger sample size for comparison of results is suggested to improve the accuracy of findings.

背景:囊性纤维化是一种慢性进行性遗传病,在世界范围内流行。随着疾病的发展,症状也会出现,这使其管理变得更具挑战性。越来越多的证据表明,CF的早期诊断有助于预防报告的营养问题,包括贫血、维生素缺乏和低蛋白血症。这项横断面研究旨在使用Shwachman-Kulczycki评分评估囊性纤维化患者的疾病严重程度,并确定其与贫血和维生素D缺乏的关系。材料和方法:从57名明确诊断的CF患者的医疗记录中收集临床和CF相关的实验室数据。在诊断时,医生使用Shwachman评分系统同时对患者进行血液采样和评分。结果:患者平均年龄为16.12±6.48岁。总分为86-100、71-85、56-70、41-55。结论:本研究中使用的评分系统可以正确反映CF患者的临床状况。然而,建议同时使用各种方法,使用更大的样本量来比较结果,以提高研究结果的准确性。
{"title":"Prevalence of Anemia and its Relation with Shwachman Score in Children with Cystic Fibrosis.","authors":"Mona Afifi,&nbsp;Maryam Hassanzad,&nbsp;Fatemeh Malek,&nbsp;Sharareh Kamfar,&nbsp;Mihan Pourabdollah,&nbsp;Poopak Farnia,&nbsp;Nooshin Baghaei,&nbsp;Ali Valinejadi,&nbsp;Ali Akbar Velayati","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Cystic fibrosis is a chronic and progressive genetic disease with a worldwide prevalence. As the disease progresses, symptoms develop, and make its management more challenging. Accumulating evidence suggests that early diagnosis of CF can significantly contribute to preventing reported nutritional problems including anemia, vitamin deficiencies, and hypoalbuminemia. This cross-sectional study was conducted to assess disease severity in cystic fibrosis patients using the Shwachman-Kulczycki score, as well as to determine its relation with anemia and vitamin D deficiency.</p><p><strong>Materials and methods: </strong>Clinical and CF-related laboratory data were collected from the medical records of 57 CF patients with a definitive diagnosis. At the time of diagnosis, physicians performed simultaneous, blood sampling and scoring of patients using the Shwachman scoring system.</p><p><strong>Results: </strong>The mean age of patients was 16.12±6.48 years. Total scores of 86-100, 71-85, 56-70, 41-55, and <40, were reported in 5.4%, 7.1%, 14.3%, 14.3%, and 58.9% of CF patients, respectively. A significant correlation was found between disease severity and patients' age (P=0.02). The analysis also showed that the disease severity was significantly higher in anemic patients when compared to non-anemics (p =0.006). Based on the results, 33 patients with normochromic, 11 patients with microcytic, and 6 patients with macrocytic anemia were diagnosed in this study. We did not find a significant difference between disease severity and vitamin D levels (P=0.150).</p><p><strong>Conclusion: </strong>The scoring system used in the current study could reflect properly the clinical status of CF patients. However, simultaneous use of various methods using a larger sample size for comparison of results is suggested to improve the accuracy of findings.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618591/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Longevity in Patients with Idiopathic Pulmonary Fibrosis Using Pirfenidone Versus Triple Therapy with Prednisolone, Azathioprine, and Acetylcysteine. 吡非尼酮与泼尼松龙、硫唑嘌呤和乙酰半胱氨酸三联疗法治疗特发性肺纤维化患者的寿命比较。
Q3 Medicine Pub Date : 2023-01-01
Mobin Soleimanian Asl, Zahra Motakef, Nazgol Behgam, Soroush Attaran, Majid Mirsadraee

Background: The effect of the combination of prednisolone, azathioprine, and acetylcysteine for the treatment of Idiopathic pulmonary fibrosis (IPF) is minimal. We aimed to investigate the effect of these drugs in case of intolerance to new anti-fibrotic drugs.

Materials and methods: This historical prospective study was performed on 91 patients with idiopathic pulmonary fibrosis who were referred to a pulmonologist in Mashhad during 2016-2020. Patients were divided into two groups, Pirfenidone which was prescribed for 46 subjects, and a combination of prednisolone, azathioprine, and acetylcysteine which was prescribed for 45 subjects. Patients were selected by convenience sampling and a life expectancy comparison between the two groups was performed by Cox regression.

Results: There were no statistically significant differences between age, gender, and drug type in the two groups at the beginning of treatment. The death rate per year in the triple-drug treatment group was 44.44% (n = 20) and in the Pirfenidone treatment group was 11.08% (n=2). Of the 65 recovered population, 49% (22 patients) were in the triple-drug treatment group, and 78% (36 patients) were in the Pirfenidone treatment group which indicated that Pirfenidone has a significant impact on reducing death rate compared to triple-drug treatment (pvalue=0.003 <0.05). Pirfenidone decreased the risk of death, compared to triple therapy (0.23 when death was set up as one in the triple-therapy group).

Conclusion: Pirfenidone has a favorable effect on increasing life expectancy and triple therapy should be considered as short-term only in subjects intolerant to anti-fibrotic.

背景:泼尼松龙、硫唑嘌呤和乙酰半胱氨酸联合治疗特发性肺纤维化(IPF)的效果很小。我们的目的是研究这些药物在对新的抗纤维化药物不耐受的情况下的效果。材料和方法:这项历史前瞻性研究对2016-2020年间转诊至马什哈德肺科医生的91名特发性肺纤维化患者进行了研究。患者被分为两组,一组为46名受试者开具的吡非尼酮,另一组为45名受试人开具的泼尼松龙、硫唑嘌呤和乙酰半胱氨酸的组合。通过方便抽样选择患者,并通过Cox回归对两组患者的预期寿命进行比较。结果:两组在治疗开始时的年龄、性别和药物类型之间没有统计学上的显著差异。三种药物治疗组的年死亡率为44.44%(n=20),吡非尼酮治疗组为11.08%(n=2)。在65名康复人群中49%(22名患者)属于三药治疗组,78%(36名患者)属于吡非尼酮治疗组,这表明与三重药物治疗相比,吡非尼尼酮在降低死亡率方面具有显著影响(p值=0.003)。
{"title":"Comparison of Longevity in Patients with Idiopathic Pulmonary Fibrosis Using Pirfenidone Versus Triple Therapy with Prednisolone, Azathioprine, and Acetylcysteine.","authors":"Mobin Soleimanian Asl,&nbsp;Zahra Motakef,&nbsp;Nazgol Behgam,&nbsp;Soroush Attaran,&nbsp;Majid Mirsadraee","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The effect of the combination of prednisolone, azathioprine, and acetylcysteine for the treatment of Idiopathic pulmonary fibrosis (IPF) is minimal. We aimed to investigate the effect of these drugs in case of intolerance to new anti-fibrotic drugs.</p><p><strong>Materials and methods: </strong>This historical prospective study was performed on 91 patients with idiopathic pulmonary fibrosis who were referred to a pulmonologist in Mashhad during 2016-2020. Patients were divided into two groups, Pirfenidone which was prescribed for 46 subjects, and a combination of prednisolone, azathioprine, and acetylcysteine which was prescribed for 45 subjects. Patients were selected by convenience sampling and a life expectancy comparison between the two groups was performed by Cox regression.</p><p><strong>Results: </strong>There were no statistically significant differences between age, gender, and drug type in the two groups at the beginning of treatment. The death rate per year in the triple-drug treatment group was 44.44% (n = 20) and in the Pirfenidone treatment group was 11.08% (n=2). Of the 65 recovered population, 49% (22 patients) were in the triple-drug treatment group, and 78% (36 patients) were in the Pirfenidone treatment group which indicated that Pirfenidone has a significant impact on reducing death rate compared to triple-drug treatment (pvalue=0.003 <0.05). Pirfenidone decreased the risk of death, compared to triple therapy (0.23 when death was set up as one in the triple-therapy group).</p><p><strong>Conclusion: </strong>Pirfenidone has a favorable effect on increasing life expectancy and triple therapy should be considered as short-term only in subjects intolerant to anti-fibrotic.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618587/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examination of the Psychometric Properties of the Persian Version of the Challenges to Stopping Smoking Scale (CSS) in Patients with Cardiovascular Disease (CVD). 心血管疾病(CVD)患者的波斯版戒烟挑战量表(CSS)的心理测量特性检查。
Q3 Medicine Pub Date : 2023-01-01
Shabboo Mohammadi, Arezoo Fallahi, Abbas Ebadi, Reza Ghanei Gheshlagh

Background: Smoking is one of the modifiable risk factors for cardiovascular disease (CVD) that is related to different types of chronic disorders. Many patients with CVD consider smoking cessation a difficult task due to various reasons. The goal of the present study was to translate the Challenges to Stopping Smoking Scale (CSS) into Persian and examine its psychometric properties.

Materials and methods: In this cross-sectional methodological study, a total of 341 patients with CVD [141 for exploratory factor analysis (EFA) and 200 for confirmatory factor analysis (CFA)] participated, and were selected using a convenience sampling method. Participants completed the Persian version of the CSS. Face, content, and construct validities were examined. Internal consistency was assessed using the McDonald's Omega and Cronbach's alpha coefficients, and stability was examined using the test-retest method.

Results: In the EFA, two factors of Internal Challenges and External Challenges were extracted that together explained 42.619% of the total variance. Cronbach's alpha coefficients of 0.740 and 0.799 and Intraclass correlation coefficients of 0.862 and 0.869 were found for Internal and External Challenges, respectively. According to the results of CFA, the three-factor model had a good fit to the data. (RMSEA: 0.059; CFI: 0.94; GFI: 0.97; NFI: 0.90; PNFI: 0.77).

Conclusion: The Persian version of the CSS has good validity and reliability, and can be used as a valid and reliable instrument in future studies.

背景:吸烟是心血管疾病(CVD)的可改变风险因素之一,与不同类型的慢性疾病有关。由于各种原因,许多心血管疾病患者认为戒烟是一项艰巨的任务。本研究的目的是将戒烟挑战量表(CSS)翻译成波斯语,并检查其心理测量特性。材料和方法:在这项横断面方法学研究中,共有341名心血管疾病患者参与[141名用于探索性因素分析(EFA),200名用于验证性因子分析(CFA)],并使用方便抽样方法进行选择。参与者完成了CSS的波斯语版本。检查了面孔、内容和结构的有效性。内部一致性使用McDonald’s Omega和Cronbach’s alpha系数进行评估,稳定性使用重测方法进行检查。结果:在全民教育中,提取了内部挑战和外部挑战两个因素,这两个因素共同解释了42.619%的总方差。内部挑战和外部挑战的Cronbachα系数分别为0.740和0.799,组内相关系数分别为0.862和0.869。根据CFA的结果,三因素模型与数据拟合良好。(RMSEA:0.059;CFI:0.94;GFI:0.97;NFI:0.90;PNFI:0.77)。
{"title":"Examination of the Psychometric Properties of the Persian Version of the Challenges to Stopping Smoking Scale (CSS) in Patients with Cardiovascular Disease (CVD).","authors":"Shabboo Mohammadi,&nbsp;Arezoo Fallahi,&nbsp;Abbas Ebadi,&nbsp;Reza Ghanei Gheshlagh","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Smoking is one of the modifiable risk factors for cardiovascular disease (CVD) that is related to different types of chronic disorders. Many patients with CVD consider smoking cessation a difficult task due to various reasons. The goal of the present study was to translate the Challenges to Stopping Smoking Scale (CSS) into Persian and examine its psychometric properties.</p><p><strong>Materials and methods: </strong>In this cross-sectional methodological study, a total of 341 patients with CVD [141 for exploratory factor analysis (EFA) and 200 for confirmatory factor analysis (CFA)] participated, and were selected using a convenience sampling method. Participants completed the Persian version of the CSS. Face, content, and construct validities were examined. Internal consistency was assessed using the McDonald's Omega and Cronbach's alpha coefficients, and stability was examined using the test-retest method.</p><p><strong>Results: </strong>In the EFA, two factors of Internal Challenges and External Challenges were extracted that together explained 42.619% of the total variance. Cronbach's alpha coefficients of 0.740 and 0.799 and Intraclass correlation coefficients of 0.862 and 0.869 were found for Internal and External Challenges, respectively. According to the results of CFA, the three-factor model had a good fit to the data. (RMSEA: 0.059; CFI: 0.94; GFI: 0.97; NFI: 0.90; PNFI: 0.77)<b>.</b></p><p><strong>Conclusion: </strong>The Persian version of the CSS has good validity and reliability, and can be used as a valid and reliable instrument in future studies.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618575/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Congenital Skin Rashes in an IVF Baby Progressed to Multisystem Langerhans Cell Histiocytosis with Lung and Bone Involvement: A Case Report and Literature Review. 体外受精婴儿先天性皮疹发展为多系统郎格罕细胞组织细胞增多症伴肺和骨受累:一例病例报告和文献综述。
Q3 Medicine Pub Date : 2023-01-01
Saeed Sadr, Seyedeh Zalfa Modarresi, Peyman Eshghi, Lobat Shahkar, Mitra Khalili, Maliheh Khoddami, Arian Karimi Rouzbahani

Langerhans cell histiocytosis is an uncommon proliferative disorder that may influence many organs; so, the clinical presentations vary. Here we describe an 85-day-old female who was born with In vitro fertilization after 10 years of infertility. She referred to us due to severe pulmonary insufficiency and congenital progressive maculopapular rash with desquamation. There were significant cystic changes in chest imaging studies. Further evaluation demonstrated lytic lesions in cranial, femoral, and humorous bones. The skin biopsy verified the diagnosis of LCH. A combination of Vinblastine, VP16, and Dexamethasone regimen was applied for the patient. In the course of the disease, she encountered multiple bilateral pneumothoraxes but didn't respond to tube thoracostomy and chemotherapy management. The patient died due to respiratory failure raised from complications of lung involvement as a multisystem LCH, 29 days later. Pediatricians should pay much more attention to the cutaneous lesions in the neonatal period especially if there is any risk factor for presenting LCH such as IVF. The lesions should be monitored closely owing to a high correlation between skin lesions and MS LCH.

郎格罕细胞组织细胞增多症是一种罕见的增殖性疾病,可能影响许多器官;因此,临床表现各不相同。在这里,我们描述了一位85天大的女性,她在不孕10年后通过体外受精出生。她因严重的肺功能不全和先天性进行性斑丘疹伴脱屑而转诊给我们。胸部影像学研究显示有明显的囊性改变。进一步评估显示颅骨、股骨和幽默骨存在溶解性病变。皮肤活检证实了LCH的诊断。患者采用长春碱、VP16和地塞米松联合方案。在疾病过程中,她遇到了多起双侧胸廓气肿,但对管胸造口术和化疗治疗没有反应。29天后,患者死于肺多系统LCH并发症引起的呼吸衰竭。儿科医生应该更多地关注新生儿时期的皮肤损伤,特别是如果有任何风险因素导致LCH,如试管婴儿。由于皮肤损伤和MS LCH之间的高度相关性,应密切监测病变。
{"title":"Congenital Skin Rashes in an IVF Baby Progressed to Multisystem Langerhans Cell Histiocytosis with Lung and Bone Involvement: A Case Report and Literature Review.","authors":"Saeed Sadr,&nbsp;Seyedeh Zalfa Modarresi,&nbsp;Peyman Eshghi,&nbsp;Lobat Shahkar,&nbsp;Mitra Khalili,&nbsp;Maliheh Khoddami,&nbsp;Arian Karimi Rouzbahani","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Langerhans cell histiocytosis is an uncommon proliferative disorder that may influence many organs; so, the clinical presentations vary. Here we describe an 85-day-old female who was born with In vitro fertilization after 10 years of infertility. She referred to us due to severe pulmonary insufficiency and congenital progressive maculopapular rash with desquamation. There were significant cystic changes in chest imaging studies. Further evaluation demonstrated lytic lesions in cranial, femoral, and humorous bones. The skin biopsy verified the diagnosis of LCH. A combination of Vinblastine, VP16, and Dexamethasone regimen was applied for the patient. In the course of the disease, she encountered multiple bilateral pneumothoraxes but didn't respond to tube thoracostomy and chemotherapy management. The patient died due to respiratory failure raised from complications of lung involvement as a multisystem LCH, 29 days later. Pediatricians should pay much more attention to the cutaneous lesions in the neonatal period especially if there is any risk factor for presenting LCH such as IVF. The lesions should be monitored closely owing to a high correlation between skin lesions and MS LCH.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618583/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SARS-CoV-2 Related Viral Respiratory Co-Infections: A Narrative Review. 严重急性呼吸系统综合征冠状病毒2型相关的病毒呼吸道共感染:叙述性综述。
Q3 Medicine Pub Date : 2023-01-01
Somayeh Shatizadeh Malekshahi, Mohammad Farahmand, Hamzeh Choobin

Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the new coronavirus originating from Wuhan, China, responsible for the illness known as coronavirus disease 2019 (COVID-19). Early experience and the recent literature have shown that co-infection of SARS-CoV-2 with another respiratory virus might occur. Similar symptoms of acute respiratory infections (ARIs) and COVID-19 represent a challenge for diagnostic and therapeutic efficacy and may modify COVID-19 outcomes.

Materials and methods: We reviewed the literature on the epidemic pattern and major learning points on important aspects of SARS-CoV-2-related viral respiratory co-infections during the COVID-19 pandemic. Databases such as PubMed, Scopus, Science Direct, and Google Scholar were used to conduct a comprehensive search.

Results: The circulation of respiratory viruses changed as the COVID-19 epidemic continues. Phenomena like viral interference, resource competition, and differences in virus-host range might explain why simultaneous viral respiratory infections have seemed to vanish with the spread of SARS-CoV-2.

Conclusion: Key research to be conducted during this pandemic should include the simultaneous screening of other respiratory pathogens with many available commercial platforms for transmission containment and appropriate clinical management.

背景:严重急性呼吸综合征冠状病毒-2(SARS-CoV-2)是起源于中国武汉的新型冠状病毒,是2019冠状病毒病(新冠肺炎)的罪魁祸首。早期经验和最近的文献表明,严重急性呼吸系统综合征冠状病毒2型可能与另一种呼吸道病毒共同感染。急性呼吸道感染(ARIs)和新冠肺炎的类似症状对诊断和治疗效果提出了挑战,并可能改变新冠肺炎的结果。材料和方法:我们回顾了新冠肺炎大流行期间与SARS-CoV-2相关的病毒性呼吸道共同感染的流行模式和重要方面的主要学习点的文献。PubMed、Scopus、Science Direct和Google Scholar等数据库被用于进行全面搜索。结果:随着新冠肺炎疫情的持续,呼吸道病毒的传播发生了变化。病毒干扰、资源竞争等现象,病毒宿主范围的差异可能解释了为什么同时发生的病毒性呼吸道感染似乎随着严重急性呼吸系统综合征冠状病毒2型的传播而消失。结论:在这场大流行期间进行的关键研究应该包括利用许多可用的商业平台同时筛查其他呼吸道病原体,以控制传播和进行适当的临床管理。
{"title":"SARS-CoV-2 Related Viral Respiratory Co-Infections: A Narrative Review.","authors":"Somayeh Shatizadeh Malekshahi,&nbsp;Mohammad Farahmand,&nbsp;Hamzeh Choobin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the new coronavirus originating from Wuhan, China, responsible for the illness known as coronavirus disease 2019 (COVID-19). Early experience and the recent literature have shown that co-infection of SARS-CoV-2 with another respiratory virus might occur. Similar symptoms of acute respiratory infections (ARIs) and COVID-19 represent a challenge for diagnostic and therapeutic efficacy and may modify COVID-19 outcomes.</p><p><strong>Materials and methods: </strong>We reviewed the literature on the epidemic pattern and major learning points on important aspects of SARS-CoV-2-related viral respiratory co-infections during the COVID-19 pandemic. Databases such as PubMed, Scopus, Science Direct, and Google Scholar were used to conduct a comprehensive search.</p><p><strong>Results: </strong>The circulation of respiratory viruses changed as the COVID-19 epidemic continues. Phenomena like viral interference, resource competition, and differences in virus-host range might explain why simultaneous viral respiratory infections have seemed to vanish with the spread of SARS-CoV-2.</p><p><strong>Conclusion: </strong>Key research to be conducted during this pandemic should include the simultaneous screening of other respiratory pathogens with many available commercial platforms for transmission containment and appropriate clinical management.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618585/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71432263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Tanaffos
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1